Compare · ACN vs OPRX
ACN vs OPRX
Side-by-side comparison of Accenture plc (ACN) and OptimizeRx Corporation (OPRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACN and OPRX operate in Real Estate (Real Estate), so they compete in similar markets.
- ACN is the larger of the two at $124.78B, about 842.8x OPRX ($148.1M).
- ACN has been more active in the news (28 items in the past 4 weeks vs 15 for OPRX).
- ACN has more recent analyst coverage (25 ratings vs 11 for OPRX).
- Company
- Accenture plc
- OptimizeRx Corporation
- Price
- -
- -
- Market cap
- $124.78B
- $148.1M
- 1M return
- +21.37%
- -
- 1Y return
- -26.80%
- -
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 28
- 15
- Recent ratings
- 25
- 11
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
Latest ACN
- Accenture to Acquire McCoy, Strengthening SAP Expertise and AI Innovation for Mid-Market
- Amendment: Chief Accounting Officer Burgum Melissa A was granted 1,034 units of Class A ordinary shares, increasing direct ownership by 12% to 9,760 units (SEC Form 4)
- CEO-The Americas Walsh John F was granted 24 units of Class A ordinary shares, increasing direct ownership by 0.09% to 26,110 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 23 units of Class A ordinary shares, increasing direct ownership by 0.24% to 9,644 units (SEC Form 4)
- Director Brudermueller Martin was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.54% to 1,690 units (SEC Form 4)
- Director Travis Tracey Thomas was granted 15 units of Class A ordinary shares, increasing direct ownership by 0.15% to 9,829 units (SEC Form 4)
- Director Uotani Masahiko was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.72% to 1,258 units (SEC Form 4)
- Director Nason Jennifer was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.98% to 932 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 47 units of Class A ordinary shares, increasing direct ownership by 0.28% to 16,794 units (SEC Form 4)
- Director Mckinstry Nancy was granted 12 units of Class A ordinary shares, increasing direct ownership by 0.15% to 8,107 units (SEC Form 4)
Latest OPRX
- Chief Executive Officer Silvestro Stephen L was granted 79,200 shares, increasing direct ownership by 43% to 262,751 units (SEC Form 4)
- Chief Business Officer D'Silva Andrew J. was granted 57,600 shares, increasing direct ownership by 132% to 101,092 units (SEC Form 4)
- Chief Legal & Admin Officer Odence-Ford Marion was granted 57,600 shares, increasing direct ownership by 64% to 148,007 units (SEC Form 4)
- CHIEF OPERATING OFFICER Merrell Brendan W. was granted 57,600 shares, increasing direct ownership by 229% to 82,787 units (SEC Form 4)
- CHIEF OPERATING OFFICER Merrell Brendan W. covered exercise/tax liability with 1,020 shares, decreasing direct ownership by 4% to 25,187 units (SEC Form 4) (for tax liability)
- Chief Executive Officer Silvestro Stephen L covered exercise/tax liability with 1,737 shares, decreasing direct ownership by 0.94% to 183,551 units (SEC Form 4) (for withholding tax)
- Chief Legal & Admin Officer Odence-Ford Marion covered exercise/tax liability with 1,529 shares, decreasing direct ownership by 2% to 90,407 units (SEC Form 4) (tax withholding)
- Chief Business Officer D'Silva Andrew J. covered exercise/tax liability with 1,243 shares, decreasing direct ownership by 3% to 43,492 units (SEC Form 4) to satisfy withholding obligation
- Chief Finance & Strat Officer Stelmakh Edward covered exercise/tax liability with 1,381 shares, decreasing direct ownership by 1% to 121,791 units (SEC Form 4)
- SEC Form S-8 filed by OptimizeRx Corporation